Show simple item record

dc.contributor.editorFerraris, Davide Maria
dc.contributor.editorMiggiano, Riccardo
dc.contributor.editorRizzi, Menico
dc.date.accessioned2021-05-01T15:42:18Z
dc.date.available2021-05-01T15:42:18Z
dc.date.issued2020
dc.identifierONIX_20210501_9783039366583_899
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/69153
dc.description.abstractTuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) and it represents a persistent public health threat for a number of complex biological and sociological reasons. According to the most recent Global Tuberculosis Report (2019) edited by the World Health Organization (WHO), TB is considered the ninth cause of death worldwide and the leading cause of mortality by a single infectious agent, with the highest rate of infections and death toll rate mostly concentrated in developing and low-income countries. We present here the editorial section to the Special Issue entitled “Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment” that includes 7 research articles and a review. The scientific contributions included in the Special Issue mainly focus on the characterization of MTB strains emerging in TB endemic countries as well as on multiple mechanisms adopted by the bacteria to resist and to adapt to antitubercular therapies.
dc.languageEnglish
dc.subject.classificationbic Book Industry Communication::G Reference, information & interdisciplinary subjects::GP Research & information: general
dc.subject.classificationbic Book Industry Communication::P Mathematics & science::PS Biology, life sciences
dc.subject.otherMycobacterium tuberculosis
dc.subject.otherline probe assay
dc.subject.othersecond-line drugs
dc.subject.otherdrug resistance
dc.subject.otherXDR-TB
dc.subject.otherMDR-TB
dc.subject.otheromics analysis
dc.subject.otherTB treatment
dc.subject.othersystem analysis
dc.subject.otherBeijing B0/W148
dc.subject.otherMycobacterium smegmatis
dc.subject.otherimidazo[1,2-b][1,2,4,5]tetrazine
dc.subject.otherMmpS5-MmpL5
dc.subject.otherefflux
dc.subject.otherdrug discovery
dc.subject.othertuberculosis
dc.subject.otherimmune activation
dc.subject.otherHLA-DR
dc.subject.otherCD38
dc.subject.othertreatment response
dc.subject.otherMycobacterium
dc.subject.othermacrophage
dc.subject.otherapoptosis
dc.subject.othereffector
dc.subject.othercytokine
dc.subject.othermicroRNA
dc.subject.otherBeijing genotype
dc.subject.otherCentral Asia Outbreak
dc.subject.othermurine infection model
dc.subject.otherVirulence
dc.subject.otherpre-XDR-TB
dc.subject.otherMycobacterium avium
dc.subject.otherunique metabolic pathways
dc.subject.othersubtractive genomics
dc.subject.otherdrug target
dc.subject.otheruncharacterized proteins
dc.subject.otherBM-MSCs
dc.subject.otherMtb
dc.subject.otherbone-homing
dc.subject.otherstem cell niche
dc.subject.otherlatent tuberculosis
dc.subject.otherrelapse
dc.subject.otherliposomes
dc.subject.otherM. tuberculosis
dc.subject.otherhost-pathogen interactions
dc.subject.otherimmune response
dc.subject.otherantitubercular drug discovery
dc.subject.otherantitubercular treatments
dc.subject.otherIL-18
dc.subject.otherIL-18BP
dc.subject.otherIL-18R
dc.subject.othergene expression
dc.titleMycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment
dc.typebook
oapen.identifier.doi10.3390/books978-3-03936-659-0
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783039366583
oapen.relation.isbn9783039366590
oapen.pages128
oapen.place.publicationBasel, Switzerland


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0/